04974481 · Active · incorporated 22 years, 9 months ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series B+
Develops first-in-class cancer therapies, including antibody-drug conjugates and T-cell engagers, through biotechnology research.
https://www.oxfordbiotherapeutics.com
Oxford Biotherapeutics Ltd is a private limited company registered at Companies House under number 04974481, incorporated on 24 November 2003, with a registered office in Oxford. Its current status on the register is active. Its filed nature of business covers research and experimental development on biotechnology (SIC 72110), other research and experimental development on natural sciences and engineering (SIC 72190) and other professional, scientific and technical activities n.e.c. (SIC 74909). Sonde has indexed 218 filings for this company, including 7 funding rounds. Its most recent round closed in February 2022, raising £3.9m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 7 | Feb 2022 | £3.9m | £2.86 |
| Round 6 | Apr 2020 | £3.7m | £8.60 |
| Round 5 | May 2019 | £6.6m | £16.40 |
| Round 4 | Apr 2018 | £4.9m | £13.35 |
| Round 3 | Apr 2017 | £4.4m | £13.52 |
| Round 2 | Apr 2016 | £5.7m | £12.49 |
Showing the 6 most recent of 7 rounds.
Showing the 10 most recent of 218 filings.
See the complete cap table with every shareholder, founder tags, dilution across 43 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.